Dr. Niesner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 E Hillcrest Blvd
1701 W. Charleston Blvd
Inglewood, CA 90301Phone+1 424-261-5789Fax+1 424-230-7341- Is this information wrong?
Education & Training
- Kirk Kerkorian School of Medicine at UNLVResidency, Internal Medicine, 2019 - 2021
- Kirk Kerkorian School of Medicine at UNLVInternship, Internal Medicine, 2017 - 2018
- University of Tennessee Health Science Center College of MedicineClass of 2018
- University of California (San Francisco)Fellowship, Clinical Neurophysiology, 2013 - 2014
- Belmont UniversityBSc, Neuroscience, Magna Cum Laude, 2008 - 2012
- Vanderbilt UniversityNon-degree, Pre-medicine, 2008 - 2012
- Belmont UniversityBSc, Psychology & Sociology, Magna Cum Laude, 2005 - 2007
Awards, Honors, & Recognition
- Full Scholarship, Visiting Elective Program: $2,800 UC Davis School of Medicine, Office of Student & Resident Diversity, 2018
- Tennessee Diversity Scholarship: $50,000 UTHSC College of Medicine, 2013-2018
- Medical Student Scholarship Program: $1,000 Kaiser Permanente Northern California (KPNC), 2017
- Join now to see all
Clinical Trials
- Systolic Blood Pressure Intervention Trial Start of enrollment: 2010 Oct 01
- Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study) Start of enrollment: 2008 May 01
Publications & Presentations
PubMed
- 233 citationsEffect of a pharmacist intervention on clinically important medication errors after hospital discharge: a randomized trial.Sunil Kripalani, Christianne L. Roumie, Anuj K. Dalal, Courtney Cawthon, Alexandra C. Businger
Annals of Internal Medicine. 2012-07-03 - 25 citationsExenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.Wojciech Garczorz, Enrique Gallego-Colon, Agnieszka Kosowska, Agnieszka Kłych-Ratuszny, Michał Woźniak
Cardiovascular Therapeutics. 2018-04-01 - 25 citationsExenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.Wojciech Garczorz, Enrique Gallego-Colon, Agnieszka Kosowska, Agnieszka Kłych-Ratuszny, Michał Woźniak
Cardiovascular Therapeutics. 2018-04-01
Professional Memberships
- AMAMember
Other Languages
- Spanish
External Links
- Research Gatehttps://www.researchgate.net/profile/Kj_Niesner
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: